Anxiolytic and antidepressant effects of emoxipine, reamberin and mexidol in experimental diabetes mellitus

Volchegorskiĭ I.A.; Miroshnichenko I.Iu.; Rassokhina L.M.; Faĭzullin R.M.; Priakhina K.E.

doi:https://doi.org/10.17116/jnevro20171175152-57

Volchegorskiĭ I.A.

Kafedra farmakologii Iuzhno-Ural'skogo gosudarstvennogo meditsinskogo universiteta Minzdrava Rossii, Cheliabinsk, Rossiia

Miroshnichenko I.Iu.

Kafedra farmakologii Cheliabinskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Rassokhina L.M.

Kafedra farmakologii Cheliabinskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Faĭzullin R.M.

GBOU VPO "Iuzhno-Ural'skiĭ gosudarstvennyĭ meditsinskiĭ universitet" , Cheliabinsk

Priakhina K.E.

GBOU VPO "Iuzhno-Ural'skiĭ gosudarstvennyĭ meditsinskiĭ universitet" , Cheliabinsk

Anxiolytic and antidepressant effects of emoxipine, reamberin and mexidol in experimental diabetes mellitus

Authors:

Volchegorskiĭ I.A., Miroshnichenko I.Iu., Rassokhina L.M., Faĭzullin R.M., Priakhina K.E.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(5): 52‑57

DOI: 10.17116/jnevro20171175152-57

Read: 5053 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Volchegorskiĭ IA, Miroshnichenko IIu, Rassokhina LM, Faĭzullin RM, Priakhina KE. Anxiolytic and antidepressant effects of emoxipine, reamberin and mexidol in experimental diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(5):52‑57. (In Russ.)
https://doi.org/10.17116/jnevro20171175152-57

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Modern concepts of sleep disturbances associated with mental disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12

Validation of the Snaith—Hamilton Pleasure Scale to assess anhedonia in patients with unipolar depression In Russia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):110-121

Psycho-emotional state and self-reported sleep quality in students with bimodality of the ability to be active in the morning and evening in the sleep—wake cycle. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):130-134

Factors supporting chronic inflammation in mental illness. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):7-15

Sex and age characteristics of stroke risk factors in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):89-97

Features of depressive disorders and suicidal behavior in multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):7-13

Effects of semaglutide on mental health. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):28-36

Gender characteristics of cardiovascular diseases psychosocial risk factors associations with sleep quality in an open urban population. Russian Journal of Preventive Medicine. 2025;(6):67-73

Dysfunctional pelvic pain in women. Russian Journal of Pain. 2025;(2):32-37

Psychodermatological aspects of psoriasis, current condition of problem. Russian Journal of Clinical Dermatology and Venereology. 2025;(4):403-411

Abstract:

Objective. To perform a comparative study of anxiolytic and antidepressant effects of derivatives of 3-oxypyridine and succinic acid (emoxipine, reamberin and mexidol) in experimental diabetes mellitus. Material and methods. An effect of emoxipine, reamberin and mexidol on manifestations of anxiety in «elevated plus maze» (EPM) and duration of «desperate behavior» (DB) in Porsolt test in rats with alloxan diabetes during medication course was studied. Alpha-lipoic (thioctic) acid (α-LA) was used as a reference drug. In additional experimental series, an effect of emoxipine, reamberin, mexidol and α-LA on the intensity of hyperglycemia in experimental DM was investigated. Results and conclusion. All studied medications used in doses equivalent to therapeutic range in humans and administered for 14 days significantly reduced manifestations of anxiety and depression in rats with alloxan diabetes. The most pronounced anxiolytic potential was demonstrated for emoxipine that emerged as the only medication in the study that reduced manifestations of anxiety not only in comparison with «alloxan diabetes-control» groups but also in comparison to «intact control». The intensity of tranquilizing activity of derivatives of 3-oxypyridine and succinic acid was similar to that of α-LA while the thymoanaleptic activity, when the drugs were administered in maximal doses to rats with experimental DM, was higher. Both emoxipine and mexidol as well as α-LA in all studied doses significantly decreased hyperglycemia in alloxan diabetes. Reamberin demonstrated only insignificant tendencies of the same trend.

Keywords:

derivatives of 3-oxypyridine and succinic acid

experimental diabetes mellitus

anxiety

depression

hyperglycemia

Authors:

Volchegorskiĭ I.A.

Kafedra farmakologii Iuzhno-Ural'skogo gosudarstvennogo meditsinskogo universiteta Minzdrava Rossii, Cheliabinsk, Rossiia

Miroshnichenko I.Iu.

Kafedra farmakologii Cheliabinskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Rassokhina L.M.

Kafedra farmakologii Cheliabinskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Faĭzullin R.M.

GBOU VPO "Iuzhno-Ural'skiĭ gosudarstvennyĭ meditsinskiĭ universitet" , Cheliabinsk

Priakhina K.E.

GBOU VPO "Iuzhno-Ural'skiĭ gosudarstvennyĭ meditsinskiĭ universitet" , Cheliabinsk

Close metadata

References:

Volchegorskii IA, Mester NV, Zotova OG. Predictors of diabetic encephalopathy. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2006;106(9):12-16. (In Russ.).
Volchegorskiĭ IA, Rassokhina LM, Miroshnichenko IYu. Dynamics of the Initial Signs of Experimental Diabetic Encephalopathy. Rossiiskii Fiziologicheskii Zhurnal im. I.M. Sechenova. 2013;99(4):491-500. (In Russ.).
Volchegorskii IA, Mester NV. The influence of 3-oxypyridine antioxidants on depression in patients with diabetes mellitus. Clinical medicine. 2007;2:40-45. (In Russ.).
McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf. 2006;5:157-168. doi:10.1517/14740338.5.1.157
Volchegorskiĭ IA, Rassokhina LM, Miroshnichenko IYu. Insulin-potentiating action of antioxidants in experimental diabetes mellitus. Problems of endocrinology. 2010;56(2):27-35. (In Russ.).
Volchegorskii IA, Rassokhina LM, Miroshnichenko IYu, Mester KM, Novoselov PN, Astakhova TV. Effect of Pro- and Antioxidants on Insulin Sensitivity and Glucose Tolerance. Bulletin of experimental biology and medicine. 2010;150(9):295-301. (In Russ.).
Volchegorskii IA, Rassokhina LM, Miroshnichenko IYu. Antihypoxic effect of 3-Hydroxypyridine and Succinic Acid Derivatives and Their Nootropic Action on Alloxan Diabetes. Experimental and clinical pharmacology. 2011;74(12):27-32. (In Russ.).
Volchegorskii IA, Miroshnichenko IYu, Rassokhina LM, Fayzullin RM, Pryakhina KE, Malkin MP, Kalugin AV. The effect of 3-oxypyridine and succinic acid derivatives on the resistance to acute cerebral ischemia. Journal of neurology and psychiatry im S.S. Korsakova. 2014;114:12:123-127. (In Russ.).
Volchegorskiĭ IA, Rassokhina LM, Miroshnichenko IYu. Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in experimental diabetes mellitus. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;113:6:50-61. (In Russ.).
Volchegorskiĭ IA, Moskvicheva MG, Chashchina EN. An effect of antioxidant drugs on symptoms of sensomotor polyneuropathy and affective disorders in patients with diabetes mellitus. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2005;105(2):41-45. (In Russ.).
Guide to carrying out preclinical researches of medicines. Under the editorship of A.N. Mironov. M.: Signature stamp and To publishing house; 2012. (In Russ.).
Volchegorsky IA, Dolgushin II, Kolesnikov OL, Tseylikman VE. Experimental modeling and laboratory assessment of adaptive reactions of an organism. Chelyabinsk: Publishing house of the Chelyabinsk state pedagogical university; 2000. (In Russ.).
Volchegorskii IA, Rassokhina LM, Miroshnichenko IYu. Antioxidants in experimental diabetes mellitus. Problems of endocrinology. 2008;54(5):43-50. (In Russ.).
Volchegorskii IA, Rassokhina LM, Miroshnichenko IYu. Cerebroprotective effects of emoxipin, reamberin, and mexidol in alloxan diabetes. Bulletin of experimental biology and medicine. 2013;155(1):63-70. (In Russ.). doi:10.1007/s10517-013-2079-3
Loche A, Simonetti F, Lobina C, Carai MAM, Colombo G, Castelli MP, Barone D, Cacciaglia R. Anti-alcohol and anxiolytic properties of a new chemical entity, GET73. Frontiers in psychiatry. 2012;3:1-15. doi:10.3389/fpsyt.2012.00008
Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nature protocols. 2007;2(2):322-328. doi:10.1038/nprot.2007.44
Buccafusco JJ. Methods of behavioral analysis in neuroscience. London New York, by CRC Press LLC; 2009.
Volchegorskii IA, Miroshnichenko IYu, Rassokhina LM, Fayzullin RM, Pryakhina KE, Kalugin AV. Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in alloxan diabetes. Rossiiskii Fiziologicheskii Zhurnal im. I.M. Sechenova. 2015;101(3):258-267. (In Russ.). doi:10.1007/s11055-016-0287-9
Volchegorskii IA, Miroshnichenko IYu, Rassokhina LM, Fayzullin RM, Pryakhina KE, Malkin MP, Kalugin AV. Anxiolytic and antidepressant action of 3-oxypiridine and succinic acid derivatives in acute phase of alloxan diabetes in rats. Experimental and clinical pharmacology. 2014;77(4):14-20. (In Russ.).
Volchegorskii IA, Miroshnichenko IYu, Rassokhina LM, Fayzullin RM, Pryakhina KE, Malkin MP, Kalugin A V. Comparative analysis of the anxiolytic effects of 3-hydroxypyridine and succinic acid derivatives. Bull Exp Biol Med. 2015;158(6):756-761. (In Russ.). doi:10.1007/s10517-015-2855-3
Chen SW, Xin Q, Kong WX, Min L, Li JF. Anxiolytic-like effect of succinic acid in mice. Life Sci. 2003;73(25):3257-3264. doi:10.1016/j.lfs.2003.06.017
Volchegorskiĭ IA, Alekseev MN, Volchegorskaia MI, Rassokhina LM. Effect of alpha-lipoic acid and mexidol on neuro- and the affective status in patients at early stages of diabetic foot syndrome. Clinical medicine. 2008;86(10):52-59. (In Russ.).